VThunter
a database for single-cell screening of virus target cells in animal kingdom
Sun Conure

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Psittaciformes; Psittacidae; Aratinga,

Latin Name: Guaruba guarouba

Tested tissues: PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0064 2021.04 iDrop PBMC Normal 9269 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Simian rotavirus A strain RRV
PBMC-B cells : 94.23% ;
PBMC-T cells : 89.90% ;
PBMC-Macrophage : 70.74% ;
PBMC-Hematopoietic stem cell : 45.42% ;
PBMC-Platelets : 43.97% ;
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Platelets : 52.22% ;
PBMC-B cells : 25.00% ;
PBMC-Macrophage : 18.33% ;
PBMC-T cells : 14.14% ;
PBMC-Hematopoietic stem cell : 11.86% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
Human immunodeficiency virus 1
PBMC-T cells : 71.72% ;
PBMC-B cells : 59.62% ;
PBMC-Macrophage : 31.19% ;
PBMC-Hematopoietic stem cell : 18.64% ;
PBMC-Platelets : 14.16% ;
Human immunodeficiency virus 2
PBMC-T cells : 71.72% ;
PBMC-B cells : 59.62% ;
PBMC-Macrophage : 31.19% ;
PBMC-Hematopoietic stem cell : 18.64% ;
PBMC-Platelets : 14.16% ;
Feline immunodeficiency virus
PBMC-T cells : 71.72% ;
PBMC-B cells : 59.62% ;
PBMC-Macrophage : 31.19% ;
PBMC-Hematopoietic stem cell : 18.64% ;
PBMC-Platelets : 14.16% ;
Foot-and-mouth disease virus
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
West Nile virus
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
Human betaherpesvirus 5
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-B cells : 1.92% ;
PBMC-Macrophage : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
Coxsackievirus A9
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
Human parechovirus 1
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
Hantaan orthohantavirus
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
Human gammaherpesvirus 8
PBMC-Platelets : 58.14% ;
PBMC-B cells : 13.46% ;
PBMC-Macrophage : 9.32% ;
PBMC-Hematopoietic stem cell : 8.14% ;
PBMC-T cells : 6.06% ;
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
Echovirus E8
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Platelets : 52.22% ;
PBMC-B cells : 25.00% ;
PBMC-Macrophage : 18.33% ;
PBMC-T cells : 14.14% ;
PBMC-Hematopoietic stem cell : 11.86% ;
Adeno-associated virus - 2
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-B cells : 9.62% ;
PBMC-Macrophage : 4.82% ;
PBMC-Platelets : 1.06% ;
PBMC-Hematopoietic stem cell : 1.02% ;
PBMC-T cells : 1.01% ;
Human rotavirus strain WA
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Platelets : 52.22% ;
PBMC-B cells : 25.00% ;
PBMC-Macrophage : 18.33% ;
PBMC-T cells : 14.14% ;
PBMC-Hematopoietic stem cell : 11.86% ;
Human gammaherpesvirus 4
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
Echovirus E1
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Platelets : 52.22% ;
PBMC-B cells : 25.00% ;
PBMC-Macrophage : 18.33% ;
PBMC-T cells : 14.14% ;
PBMC-Hematopoietic stem cell : 11.86% ;
Human parvovirus B19
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
Human metapneumovirus
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
Mammalian orthoreovirus
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Macrophage : 0.32% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Equid alphaherpesvirus 1
PBMC-B cells : 53.85% ;
PBMC-Macrophage : 53.70% ;
PBMC-Platelets : 43.97% ;
PBMC-T cells : 42.42% ;
PBMC-Hematopoietic stem cell : 23.05% ;
PBMC-Macrophage : 48.23% ;
PBMC-T cells : 39.39% ;
PBMC-B cells : 38.46% ;
PBMC-Hematopoietic stem cell : 11.19% ;
PBMC-Platelets : 8.46% ;
Influenza A virus
PBMC-B cells : 51.92% ;
PBMC-Macrophage : 40.19% ;
PBMC-T cells : 20.20% ;
PBMC-Platelets : 19.24% ;
PBMC-Hematopoietic stem cell : 15.93% ;
PBMC-Macrophage : 15.43% ;
PBMC-B cells : 7.69% ;
PBMC-T cells : 6.06% ;
PBMC-Platelets : 4.86% ;
PBMC-Hematopoietic stem cell : 3.05% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-Macrophage : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Macrophage : 0.32% ;
PBMC-Platelets : 0.21% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 0.00% ;
Lassa mammarenavirus
PBMC-Macrophage : 49.20% ;
PBMC-T cells : 29.29% ;
PBMC-B cells : 25.00% ;
PBMC-Hematopoietic stem cell : 15.25% ;
PBMC-Platelets : 14.80% ;
PBMC-Macrophage : 4.82% ;
PBMC-Platelets : 4.65% ;
PBMC-B cells : 3.85% ;
PBMC-Hematopoietic stem cell : 1.02% ;
PBMC-T cells : 1.01% ;
PBMC-T cells : 2.02% ;
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.42% ;
PBMC-B cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
Hepacivirus C
PBMC-T cells : 44.44% ;
PBMC-Macrophage : 39.55% ;
PBMC-B cells : 21.15% ;
PBMC-Hematopoietic stem cell : 16.61% ;
PBMC-Platelets : 12.90% ;
PBMC-Macrophage : 19.94% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-B cells : 3.85% ;
PBMC-Platelets : 2.96% ;
PBMC-T cells : 1.01% ;
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
PBMC-T cells : 7.07% ;
PBMC-Macrophage : 3.54% ;
PBMC-B cells : 1.92% ;
PBMC-Platelets : 1.69% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-Macrophage : 2.25% ;
PBMC-Platelets : 2.11% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 1.36% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 1.92% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-Macrophage : 0.00% ;
Chikungunya virus
PBMC-B cells : 44.23% ;
PBMC-T cells : 35.35% ;
PBMC-Macrophage : 29.90% ;
PBMC-Platelets : 13.32% ;
PBMC-Hematopoietic stem cell : 13.22% ;
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Bovine leukemia virus
PBMC-Macrophage : 32.80% ;
PBMC-B cells : 28.85% ;
PBMC-T cells : 23.23% ;
PBMC-Hematopoietic stem cell : 9.83% ;
PBMC-Platelets : 9.73% ;
Enterovirus A71
PBMC-T cells : 28.28% ;
PBMC-Macrophage : 18.01% ;
PBMC-B cells : 5.77% ;
PBMC-Hematopoietic stem cell : 0.68% ;
PBMC-Platelets : 0.21% ;
PBMC-Macrophage : 7.72% ;
PBMC-T cells : 5.05% ;
PBMC-Platelets : 2.11% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 0.68% ;
Coxsackievirus B1
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Human alphaherpesvirus 1
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 0.00% ;
Human mastadenovirus C
PBMC-Macrophage : 24.76% ;
PBMC-T cells : 16.16% ;
PBMC-B cells : 7.69% ;
PBMC-Platelets : 5.71% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-Macrophage : 1.93% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Xenotropic murine leukemia virus
PBMC-B cells : 23.08% ;
PBMC-T cells : 12.12% ;
PBMC-Macrophage : 11.58% ;
PBMC-Platelets : 6.98% ;
PBMC-Hematopoietic stem cell : 3.73% ;
Polytropic murine leukemia virus
PBMC-B cells : 23.08% ;
PBMC-T cells : 12.12% ;
PBMC-Macrophage : 11.58% ;
PBMC-Platelets : 6.98% ;
PBMC-Hematopoietic stem cell : 3.73% ;
Japanese encephalitis virus
PBMC-Platelets : 21.99% ;
PBMC-Macrophage : 8.68% ;
PBMC-Hematopoietic stem cell : 6.44% ;
PBMC-B cells : 5.77% ;
PBMC-T cells : 2.02% ;
Dengue virus
PBMC-Macrophage : 19.94% ;
PBMC-Hematopoietic stem cell : 5.08% ;
PBMC-B cells : 3.85% ;
PBMC-Platelets : 2.96% ;
PBMC-T cells : 1.01% ;
PBMC-T cells : 2.02% ;
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.42% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Ebola virus
PBMC-Macrophage : 18.33% ;
PBMC-B cells : 3.85% ;
PBMC-Platelets : 2.54% ;
PBMC-T cells : 2.02% ;
PBMC-Hematopoietic stem cell : 1.36% ;
PBMC-B cells : 5.77% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 1.48% ;
PBMC-T cells : 1.01% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-T cells : 2.02% ;
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.42% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Human papillomavirus type 16
PBMC-Platelets : 17.34% ;
PBMC-T cells : 11.11% ;
PBMC-B cells : 9.62% ;
PBMC-Macrophage : 6.11% ;
PBMC-Hematopoietic stem cell : 3.05% ;
PBMC-Macrophage : 8.04% ;
PBMC-B cells : 7.69% ;
PBMC-T cells : 5.05% ;
PBMC-Platelets : 4.23% ;
PBMC-Hematopoietic stem cell : 1.69% ;
Vesicular stomatitis virus
PBMC-Macrophage : 15.43% ;
PBMC-B cells : 7.69% ;
PBMC-T cells : 6.06% ;
PBMC-Platelets : 4.86% ;
PBMC-Hematopoietic stem cell : 3.05% ;
Respiratory syncytial virus
PBMC-T cells : 15.15% ;
PBMC-B cells : 3.85% ;
PBMC-Macrophage : 2.57% ;
PBMC-Platelets : 1.27% ;
PBMC-Hematopoietic stem cell : 1.02% ;
Simian sarcoma-associated virus
PBMC-T cells : 13.13% ;
PBMC-Macrophage : 2.57% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Platelets : 0.21% ;
Gibbon ape leukemia virus
PBMC-T cells : 13.13% ;
PBMC-Macrophage : 2.57% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Platelets : 0.21% ;
PBMC-B cells : 9.62% ;
PBMC-Macrophage : 6.43% ;
PBMC-T cells : 6.06% ;
PBMC-Hematopoietic stem cell : 1.69% ;
PBMC-Platelets : 1.06% ;
Feline leukemia virus strain B/lambda-B1
PBMC-T cells : 13.13% ;
PBMC-Macrophage : 2.57% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Platelets : 0.21% ;
PBMC-B cells : 9.62% ;
PBMC-Macrophage : 6.43% ;
PBMC-T cells : 6.06% ;
PBMC-Hematopoietic stem cell : 1.69% ;
PBMC-Platelets : 1.06% ;
Canine parvovirus
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
Guanarito mammarenavirus
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
Machupo mammarenavirus
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
Mouse mammary tumor virus
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
Feline panleukopenia virus
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
Argentinian mammarenavirus
PBMC-B cells : 11.54% ;
PBMC-T cells : 9.09% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 4.44% ;
PBMC-Hematopoietic stem cell : 1.02% ;
JC polyomavirus
PBMC-Platelets : 11.21% ;
PBMC-Macrophage : 5.47% ;
PBMC-T cells : 4.04% ;
PBMC-Hematopoietic stem cell : 2.71% ;
PBMC-B cells : 1.92% ;
Amphotropic murine leukemia virus
PBMC-B cells : 9.62% ;
PBMC-Macrophage : 6.43% ;
PBMC-T cells : 6.06% ;
PBMC-Hematopoietic stem cell : 1.69% ;
PBMC-Platelets : 1.06% ;
Varicella Zoster Virus
PBMC-Macrophage : 8.36% ;
PBMC-T cells : 8.08% ;
PBMC-Platelets : 3.59% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 1.36% ;
Human alphaherpesvirus 3
PBMC-Macrophage : 8.36% ;
PBMC-T cells : 8.08% ;
PBMC-Platelets : 3.59% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 1.36% ;
Porcine reproductive and respiratory syndrome virus
PBMC-Macrophage : 8.04% ;
PBMC-B cells : 7.69% ;
PBMC-T cells : 5.05% ;
PBMC-Platelets : 4.23% ;
PBMC-Hematopoietic stem cell : 1.69% ;
PBMC-Macrophage : 1.61% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Coxsackievirus A16
PBMC-Macrophage : 7.72% ;
PBMC-T cells : 5.05% ;
PBMC-Platelets : 2.11% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 0.68% ;
Marburg marburgvirus
PBMC-B cells : 5.77% ;
PBMC-Macrophage : 5.14% ;
PBMC-Platelets : 1.48% ;
PBMC-T cells : 1.01% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-T cells : 2.02% ;
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.42% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Lymphocytic choriomeningitis mammarenavirus
PBMC-Macrophage : 4.82% ;
PBMC-Platelets : 4.65% ;
PBMC-B cells : 3.85% ;
PBMC-Hematopoietic stem cell : 1.02% ;
PBMC-T cells : 1.01% ;
PBMC-T cells : 2.02% ;
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.42% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Latino mammarenavirus
PBMC-Macrophage : 4.82% ;
PBMC-Platelets : 4.65% ;
PBMC-B cells : 3.85% ;
PBMC-Hematopoietic stem cell : 1.02% ;
PBMC-T cells : 1.01% ;
Oliveros mammarenavirus
PBMC-Macrophage : 4.82% ;
PBMC-Platelets : 4.65% ;
PBMC-B cells : 3.85% ;
PBMC-Hematopoietic stem cell : 1.02% ;
PBMC-T cells : 1.01% ;
Feline leukemia virus strain C/FA27
PBMC-B cells : 3.85% ;
PBMC-Platelets : 3.59% ;
PBMC-Macrophage : 3.22% ;
PBMC-Hematopoietic stem cell : 1.36% ;
PBMC-T cells : 1.01% ;
Severe acute respiratory syndrome coronavirus 2
PBMC-Platelets : 3.59% ;
PBMC-Macrophage : 2.57% ;
PBMC-T cells : 2.02% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-B cells : 0.00% ;
PBMC-Macrophage : 2.25% ;
PBMC-Platelets : 2.11% ;
PBMC-B cells : 1.92% ;
PBMC-Hematopoietic stem cell : 1.36% ;
PBMC-T cells : 0.00% ;
Hepatitis E virus
PBMC-T cells : 3.03% ;
PBMC-B cells : 1.92% ;
PBMC-Macrophage : 0.32% ;
PBMC-Platelets : 0.21% ;
PBMC-Hematopoietic stem cell : 0.00% ;
Zika virus
PBMC-T cells : 2.02% ;
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.42% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Ecotropic murine leukemia virus
PBMC-B cells : 1.92% ;
PBMC-Macrophage : 0.32% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
Coxsackievirus A10
PBMC-B cells : 1.92% ;
PBMC-Macrophage : 1.29% ;
PBMC-Platelets : 0.42% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-T cells : 0.00% ;
Onyong-nyong virus
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 0.00% ;
Coxsackievirus B3
PBMC-Macrophage : 0.96% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
Human mastadenovirus B
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Coxsackievirus B2
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Human mastadenovirus F
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Coxsackievirus B4
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
Human mastadenovirus A
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Ross River virus
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 0.00% ;
Mayaro virus
PBMC-Macrophage : 0.96% ;
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 0.00% ;
Human mastadenovirus D
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Coxsackievirus B5
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Coxsackievirus B6
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Human mastadenovirus E
PBMC-Macrophage : 0.96% ;
PBMC-Platelets : 0.00% ;
PBMC-T cells : 0.00% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
Encephalomyocarditis virus
PBMC-Macrophage : 0.64% ;
PBMC-Platelets : 0.21% ;
PBMC-Hematopoietic stem cell : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-T cells : 0.00% ;
Hendra henipavirus
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Macrophage : 0.32% ;
PBMC-Platelets : 0.21% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 0.00% ;
Nipah henipavirus
PBMC-Hematopoietic stem cell : 0.34% ;
PBMC-Macrophage : 0.32% ;
PBMC-Platelets : 0.21% ;
PBMC-T cells : 0.00% ;
PBMC-B cells : 0.00% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China